Can a Multistakeholder Initiative Improve Transparency and Accountability in the Pharmaceutical Sector? Evidence From the Medicines Transparency Alliance
The Lancet Global Health - United Kingdom
doi 10.1016/s2214-109x(17)30113-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2017
Authors
Publisher
Elsevier BV